StemGen(SGNI)
$0.100.00 (0.00%)
SGNI
StemGen financials statements
$0.10
At close:0.00 (0.00%)
StemGen (SGNI) Income Statement
3 Followers
StemGen Income Statement
Last quarter (Q3 2022), StemGen's total revenue was $0.00. In Q3, StemGen's net income was $-199.00K. See StemGen’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 21 | Jun 20 | Jun 19 | Jun 18 | Jun 17 |
|---|---|---|---|---|---|
| $ 39.00K | $ 19.35K | $ 22.06K | $ 0.00 | $ 0.00 | |
| $ 8.55K | $ 10.78K | $ 13.55K | $ 0.00 | $ 0.00 | |
| $ 252.47K | $ 77.85K | $ 256.73K | $ 32.33K | $ 7.55K | |
| Depreciation and Amortization | $ 112.48K | $ 19.37K | $ 60.00K | $ 11.97K | $ 52.52K |
| $ -179.87K | $ -70.60K | $ -308.00K | $ 0.00 | $ 7.55K | |
| $ -244.00K | $ -67.07K | $ -243.00K | $ -32.33K | $ 7.55K | |
| $ -189.00K | $ -163.70K | $ -182.00K | $ 38.44K | $ -77.55K | |
| $ -433.00K | $ -230.77K | $ -426.00K | $ 6.12K | $ -70.00K | |
| $ -433.00K | $ -230.77K | $ -426.00K | $ 6.12K | $ -70.00K | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.01 | $ -0.01 | $ -0.02 | $ 0.00 | $ -0.01 |
| Diluted EPS | $ -0.01 | $ -0.01 | $ -0.02 | $ 0.00 | $ -0.01 |
| Weighted Average Shares Outstanding | 45.60M | 45.43M | 24.45M | 14.08M | 14.08M |
| Weighted Average Shares Outstanding (Diluted) | 45.60M | 45.43M | 24.45M | 14.08M | 14.08M |
Currency in USD
